United States · Platforms & data · The Motley Fool

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?

Published by The Motley Fool · United States 1 h ago

Amgen trades at a lower valuation multiple, but Johnson & Johnson's fortress balance sheet and stronger free cash flow tell a different story about financial resilience.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

MarketWatch

The Social Security Administration wants more babies signed up for ‘Trump accounts.’ But there’s still a catch.

MarketBeat

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Shareholders Set to Receive $0.03 Dividend

Seeking Alpha

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?

Share

Also worth reading

The Social Security Administration wants more babies signed up for ‘Trump accounts.’ But there’s still a catch.

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Shareholders Set to Receive $0.03 Dividend

Couche-Tard makes bid for Cumberland Farms: report

Iranian lethal plots against Americans at ’advanced stages,’ Reuters reports

Myro (MYRO) Price Prediction: 2025, 2026, 2030

Technology Drives the Future of Travel: JETOUR Continues to Expand Its "Travel+" Ecosystem